About

Michael S. Cookson is a distinguished urologic oncologist whose research has profoundly shaped the surgical management of prostate and bladder cancer. His work spans two transformative decades in urology, focusing primarily on radical prostatectomy techniques, robotic-assisted surgery, and radical cystectomy outcomes. Cookson played a pivotal role in establishing evidence-based guidelines, most notably co-authoring the landmark 2007 AUA Guidelines for the Management of Clinically Localized Prostate Cancer, which has accumulated over 1,100 citations and remains a foundational clinical reference. His comparative studies of robotic-assisted laparoscopic radical prostatectomy versus open retropubic approaches — examining surgical margins, postoperative pain, hospital stay, and biochemical recurrence — helped define the clinical value of minimally invasive techniques during a critical period of technological adoption. Perhaps most significantly, Cookson served as a principal investigator on the RAZOR trial, a landmark phase 3 randomized controlled study demonstrating the non-inferiority of robotic radical cystectomy, now cited over 760 times. His rigorous, outcomes-driven research has directly influenced surgical decision-making globally, earning him recognition as one of the most impactful voices in contemporary urologic oncology.

Research Focus

Key Achievements

17
H-Index
25
Papers
3,522
Total Citations
141
Avg Citations/Paper
🏆 Most Cited Paper
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
1,112 citations · 2007
📈 Most Prolific Year: 2007 (5 Papers)
🤝 Key Collaborators: 97
🏛 Institutions: American Urological Association, University of Oklahoma, Vanderbilt University Medical Center, Emory University, University of Oklahoma Health Sciences Center, Vanderbilt University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago